Loading...
XSHE300314
Market cap404mUSD
Jan 10, Last price  
10.31CNY
1D
-3.10%
1Q
-18.56%
Jan 2017
-51.51%
IPO
30.01%
Name

Ningbo David Medical Device Co Ltd

Chart & Performance

D1W1MN
XSHE:300314 chart
P/E
20.12
P/S
4.80
EPS
0.51
Div Yield, %
1.45%
Shrs. gr., 5y
0.09%
Rev. gr., 5y
15.54%
Revenues
618m
+22.18%
140,407,074149,790,265177,690,663206,741,295255,790,389217,245,092227,181,354219,427,411264,948,777303,905,401300,298,175356,352,075459,530,603474,132,641506,036,692618,298,238
Net income
148m
+51.62%
24,807,17228,956,96138,591,78453,968,74473,866,83564,071,72853,606,57544,934,20262,165,92847,033,16928,812,63862,056,592136,190,37580,206,69197,358,600147,610,911
CFO
135m
+21.18%
12,100,40041,220,88556,775,33167,018,85994,528,29756,490,57767,787,05648,409,95476,951,21954,740,45369,954,90088,569,835137,730,04751,480,031111,569,973135,198,383
Dividend
Jun 19, 20240.18 CNY/sh

Profile

Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and distribution of medical equipment in worldwide. The company primarily provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It also offers other products, such as infusion pumps, transcutaneous jaundice detectors, infant t-piece resuscitators, air/oxygen blenders, low pressure aspirators, infant oxygen hoods, far infrared heaters, and infant head fixing units. The company offers its products under David brand name. Ningbo David Medical Device Co., Ltd. was founded in 1992 and is headquartered in Ningbo, China.
URL
https://www.nbdavid.com/
IPO date
May 08, 2012
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
618,298
22.18%
506,037
6.73%
Cost of revenue
446,484
380,778
Unusual Expense (Income)
NOPBT
171,814
125,258
NOPBT Margin
27.79%
24.75%
Operating Taxes
18,614
14,338
Tax Rate
10.83%
11.45%
NOPAT
153,200
110,920
Net income
147,611
51.62%
97,359
21.38%
Dividends
(43,200)
(28,800)
Dividend yield
0.99%
0.77%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
3,019
Long-term debt
17,957
23,026
Deferred revenue
4,195
4,202
Other long-term liabilities
1
Net debt
(611,527)
(715,795)
Cash flow
Cash from operating activities
135,198
111,570
CAPEX
(40,392)
Cash from investing activities
71,761
Cash from financing activities
FCF
117,029
117,809
Balance
Cash
791,630
741,839
Long term investments
(162,146)
Excess cash
598,569
716,537
Stockholders' equity
901,107
883,770
Invested Capital
578,077
342,522
ROIC
33.28%
33.56%
ROCE
14.60%
11.82%
EV
Common stock shares outstanding
289,433
288,000
Price
15.14
16.64%
12.98
-4.56%
Market cap
4,382,018
17.22%
3,738,240
-4.56%
EV
3,770,491
3,022,445
EBITDA
199,134
150,767
EV/EBITDA
18.93
20.05
Interest
928
350
Interest/NOPBT
0.54%
0.28%